brand logo

Am Fam Physician. 2005;72(8):1600-1601

Colorectal cancer screening options endorsed by major organizations include fecal occult blood testing (FOBT). This is based on clinical trials showing that a protocol of testing six samples obtained by a patient at home reduced morbidity and mortality. In practice, however, physicians often substitute FOBT of a single specimen obtained during a digital rectal examination in the office. Collins and colleagues conducted a prospective cohort study to compare the sensitivity and specificity of office FOBT with home FOBT.

The study population consisted of randomly recruited patients 50 to 75 years of age at primary care clinics in 13 Veterans Affairs medical centers. Nearly 97 percent of the patients were men. Those with pre-existing lower gastrointestinal tract disease and abdominal symptoms that required a medical evaluation were excluded. Enrolled patients underwent a complete physical examination, including digital rectal examination. Office FOBT was performed on one stool sample. Patients then completed home FOBT and underwent colonoscopy of the cecum. Visible polypoid lesions were removed or biopsied and sent to pathology. Results were interpreted independently by three pathologists who were blinded to FOBT results. Of the 3,121 original patients, 2,665 completed all parts of the study and were included in the analysis.

More than one half of all patients had polypoid lesions identified on colonoscopy examination, and 284 patients (10.7 percent) were found to have pathology consistent with advanced neoplasia (i.e., tubular adenoma of at least 1 cm, villous adenoma, high-grade dysplasia, or cancer). A positive result on home FOBT had 23.9 percent sensitivity and 93.8 percent specificity for advanced neoplasia; in contrast, office FOBT had 4.9 percent sensitivity and 97.1 percent specificity. Although a positive result on home FOBT indicated that a patient was nearly four times as likely to have advanced neoplasia, a positive result on office FOBT was statistically insignificant; a negative result did not affect likelihood of neoplasia. Finally, adding the office test to the home test did not improve the sensitivity of home FOBT.

The authors conclude that their results do not support the practice of office FOBT of a single stool sample for colorectal cancer screening. Based on a trend toward increased likelihood of advanced neoplasia in patients with positive results on office FOBT, they recommend a follow-up colonoscopy (rather than repeat testing) for these patients. Because a negative result on office FOBT is essentially meaningless, they recommend follow-up home FOBT or lower endoscopy.

Continue Reading

More in AFP

Copyright © 2005 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See for copyright questions and/or permission requests.